Table 4.
Study | Drugs | Duration of treatment | Number of subjects in study | Panel | Total hair count | Non-vellus hair count |
---|---|---|---|---|---|---|
This study | Minoxidil oral 5 mg/day | 24 weeks | 30 | 100.0% | 19.2% | 23.5% |
Olsen et al.a | 5% Minoxidil solution, vs 2% minoxidil vs placebo | 48 weeks | 393 | 57.9% vs 40.8% vs 23.2% | 12.3% vs 8.8 vs 2.6% | |
Olsen et al.b | 5% Minoxidil foam, vs placebo | 16 weeks | 352 | 38.3% vs 5.2% | 13.4% vs 3.4% | |
Roberts et al.c | Finasteride 1 mg/day, vs placebo | 12 months | 693 | 54% vs 3% | 9.0% vs − 2.1 | |
Neste et al.d | Finasteride 1 mg/day, vs placebo | 48 weeks | 212 | 7.2 vs − 10.1 (8.3% better) | ||
Harcha et al.e | Dutasteride 0.5 mg/day vs finasteride 1 mg/day vs placebo | 24 weeks | 153 | 47% vs 36% vs 7% | 11.67% vs 7.4% vs − 0.64% |
aOlsen EA et al. J Am Acad Dermatol. 2002;47(3):377–85
bOlsen EA et al. J Am Acad Dermatol. 2007;57(5):767–74
cRoberts JL et al. J Am Acad Dermatol. 1999;41(4):555–63
dNeste D et al. Br J Dermatol. 2000;143(4):804–810
eHarcha WG et al. J Am Acad Dermatol. 2014;70(3):489–98